Project Preservation
Clinical Intake

This questionnaire takes approximately 8–10 minutes. Your answers are reviewed by a licensed provider before any protocol is recommended.

01 of 12

Let's start with you.

Basic information used to create your clinical record.

Your provider must be licensed in your state
02 of 12

Body composition.

Used to calculate clinical dosing thresholds and assess baseline metabolic status.

⚠ Yellow flag — provider review before peptide initiation
03 of 12

Medical history.

Select anything that applies to you, past or present. This directly shapes your protocol.

Select all that apply
Yes
No
04 of 12

What you're currently taking.

Interactions between peptides and certain medications require provider attention. Please be thorough.

Yes
No
Include name, dose, and frequency if known

⚠ Potential interaction with GLP-1 and glucose-regulating peptides
Yes
No
⛔ Red flag — provider review required before GLP-1 initiation
e.g. Warfarin, Eliquis, Xarelto, Plavix, daily aspirin 325mg+
Yes
No
⚠ Yellow flag — relevant for peptide injection site guidance
e.g. Prednisone, Methotrexate, Tacrolimus, biologics
Yes
No
⚠ Yellow flag — may affect immune-modulating peptide protocols

Yes
No
Include dose and frequency if known

Yes
No
Yes
No
⚠ Yellow flag — relevant for compounded peptide vial selection
05 of 12

Reproductive health.

Hormonal status significantly affects peptide protocol design and safety thresholds.

Yes
No
⛔ Red flag — peptide therapy is contraindicated during pregnancy and active conception attempts. Your intake will be paused and a provider will follow up.
Yes
No
⛔ Red flag — provider review required. Most peptide protocols are not recommended during lactation.
e.g. birth control pill, IUD, HRT, testosterone, DHEA
Yes
No
Yes
No
06 of 12

Surgical history.

Prior surgeries, especially GI-related, affect peptide tolerability and dosing.

Yes
No
e.g. gastric sleeve, gastric bypass, lap band
Yes
No
⚠ Yellow flag — GLP-1 protocols require modified initiation approach
Yes
No
⚠ Yellow flag — history reviewed by provider before growth-factor peptides
07 of 12

Family health history.

Genetic predispositions can influence which protocols are appropriate for long-term use.

Select all that apply
08 of 12

Digestive and mental health.

GI tolerance and mental health baseline are both relevant to protocol selection and support planning.

Select all that apply

This helps us select protocols least likely to affect mood and sleep architecture
Yes
No
Yes
No
Yes
No
09 of 12

How you live.

Lifestyle context helps us personalize your protocol and set realistic expectations.



This information is strictly clinical and confidential. It directly informs dosing decisions.
10 of 12

Prior experience.

Your history with peptides and GLP-1s shapes where we start and what to watch for.

e.g. Semaglutide (Ozempic, Wegovy), Tirzepatide (Mounjaro, Zepbound), Liraglutide
Yes
No

e.g. BPC-157, TB-500, Ipamorelin, CJC-1295, PT-141, Epithalon, MOTS-C
Yes
No
Yes
No
⚠ Yellow flag — prior adverse peptide reactions reviewed by provider
Yes
No
⚠ Yellow flag — concurrent protocols require provider coordination
11 of 12

What you're here for.

Your goals guide protocol selection. Be specific — our providers read every word.

Select up to three
This becomes your primary treatment objective
12 of 12

Review and consent.

Please read the statements below carefully. Your signature confirms accuracy and authorizes clinical review.

Type your full name as it appears on your intake to confirm agreement

You're in the system.

Your intake has been received. A licensed provider will review your information within 24–48 hours. You'll hear from us via text with your next steps.

Welcome to Project Preservation.